Search research articles
Contact Us
Filters
Showing results (721-730 of 763) with videos related to
Page
of 77
Sort By:
Psychological Medicine
|
March 12, 2025
Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach
Isabelle Scott, Emmeke Aarts, Cassandra Wannan, et al.
Schizophrenia Bulletin
|
September 6, 2024
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
Paul Møller, Barnaby Nelson, Patrick D McGorry, et al.
Bjpsych Open
|
September 8, 2022
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
Nicholas Cheng, Alison McLaverty, Barnaby Nelson, et al.
Brain, Behavior, and Immunity
|
October 8, 2021
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
Subash Raj Susai, David Mongan, Colm Healy, et al.
Behaviour Research and Therapy
|
December 3, 2019
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial
Jessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, et al.
BMC Medicine
|
January 18, 2020
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Michael Berk, Mohammadreza Mohebbi, Olivia M Dean, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
Psychotherapy and Psychosomatics
|
September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis
Jessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Early Intervention in Psychiatry
|
March 29, 2014
Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study
Rosemary Purcell, Anthony F Jorm, Ian B Hickie, et al.
Page
of 77
Search research articles
Search
Showing results (721-730 of 763) with videos related to
Sort By:
Page
of 77
Psychological Medicine
|
March 12, 2025
Characterising symptomatic substates in individuals on the psychosis continuum: a hidden Markov modelling approach
Isabelle Scott, Emmeke Aarts, Cassandra Wannan, et al.
Schizophrenia Bulletin
|
September 6, 2024
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
Paul Møller, Barnaby Nelson, Patrick D McGorry, et al.
Bjpsych Open
|
September 8, 2022
Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
Nicholas Cheng, Alison McLaverty, Barnaby Nelson, et al.
Brain, Behavior, and Immunity
|
October 8, 2021
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
Subash Raj Susai, David Mongan, Colm Healy, et al.
Behaviour Research and Therapy
|
December 3, 2019
Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial
Jessica A Hartmann, Stefanie J Schmidt, Patrick D McGorry, et al.
BMC Medicine
|
January 18, 2020
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Michael Berk, Mohammadreza Mohebbi, Olivia M Dean, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
The Journal of Antimicrobial Chemotherapy
|
July 2, 2011
Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline
Heidi S M Ammerlaan, Jan A J W Kluytmans, Hanneke Berkhout, et al.
Psychotherapy and Psychosomatics
|
September 14, 2017
Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis
Jessica A Hartmann, Patrick D McGorry, Stefanie J Schmidt, et al.
Early Intervention in Psychiatry
|
March 29, 2014
Demographic and clinical characteristics of young people seeking help at youth mental health services: baseline findings of the Transitions Study
Rosemary Purcell, Anthony F Jorm, Ian B Hickie, et al.
Page
of 77